These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Outcomes of Convalescent Plasma with Defined High versus Lower Neutralizing Antibody Titers against SARS-CoV-2 among Hospitalized Patients: CoronaVirus Inactivating Plasma (CoVIP) Study. Bartelt LA; Markmann AJ; Nelson B; Keys J; Root H; Henderson HI; Kuruc J; Baker C; Bhowmik DR; Hou YJ; Premkumar L; Cornaby C; Schmitz JL; Weiss S; Park Y; Baric R; de Silva AM; Lachiewicz A; Napravnik S; van Duin D; Margolis DM mBio; 2022 Oct; 13(5):e0175122. PubMed ID: 36135380 [TBL] [Abstract][Full Text] [Related]
8. A Multicenter, Prospective, Observational, Cohort-Controlled Study of Clinical Outcomes Following Coronavirus Disease 2019 (COVID-19) Convalescent Plasma Therapy in Hospitalized Patients With COVID-19. Chauhan L; Pattee J; Ford J; Thomas C; Lesteberg K; Richards E; Bernas CA; Loi M; Dumont L; Annen K; Berg M; Zirbes M; Knight V; Miller A; Jenkins TC; Bennett TD; Monkowski D; Boxer RS; Beckham JD Clin Infect Dis; 2022 Aug; 75(1):e466-e472. PubMed ID: 34549274 [TBL] [Abstract][Full Text] [Related]
9. High-titer post-vaccine COVID-19 convalescent plasma for immunocompromised patients during the first omicron surge. Tayyar R; Wong LK; Dahlen A; Shu E; Pandey S; Liu AY Transpl Infect Dis; 2023 Apr; 25(2):e14055. PubMed ID: 36929619 [TBL] [Abstract][Full Text] [Related]
10. Convalescent Plasma for Hospitalized COVID-19 Patients: A Single-Center Experience. Franchini M; Glingani C; Donno G; Lucchini G; Beccaria M; Amato M; Castelli GP; Bianciardi L; Pagani M; Ghirardini M; Puma G; Presciuttini B; Costantino MT; Frigato M; Crosato V; Tiecco G; Mulè A; Papalia DA; Inglese F; Spreafico F; Garuti M; Pecoriello A; Cervi G; Greco G; Galavotti V; Santini T; Berselli A; Montalto C; Bertoletti R; Bellometti SA; Capuzzo E; Benazzi D; Grisolia G; Pajola F; Stradoni R; Zani M; Verzola A; Codeluppi V; Vesentini S; Bellocchio E; Candini M; Ambrosi G; Carandina F; Scarduelli C; Reggiani A; Casari S; On Behalf Of Convalescent Plasma Study Group Life (Basel); 2022 Mar; 12(3):. PubMed ID: 35330170 [TBL] [Abstract][Full Text] [Related]
11. Reduced Mortality among COVID-19 ICU Patients after Treatment with HemoClear Convalescent Plasma in Suriname. Bihariesingh-Sanchit R; Bansie R; Ramdhani N; Mangroo R; Bustamente D; Diaz E; Fung A Foek C; Thakoer I; Vreden S; Choudhry Z; van 't Wout AB; Diavatopoulos DA; Nierich AP mBio; 2023 Apr; 14(2):e0337922. PubMed ID: 36815780 [TBL] [Abstract][Full Text] [Related]
12. Outcome of SARS CoV-2 inpatients treated with convalescent plasma: One-year of data from the Veneto region (Italy) Registry. De Silvestro G; Marson P; La Raja M; Cattelan AM; Guarnieri G; Monticelli J; Tiberio I; Vianello A; Gandini G; Gessoni G; Fiorin F; Sardella C; Astolfi L; Saia M; Eur J Intern Med; 2022 Mar; 97():42-49. PubMed ID: 34980505 [TBL] [Abstract][Full Text] [Related]
13. Donors for SARS-CoV-2 Convalescent Plasma for a Controlled Clinical Trial: Donor Characteristics, Content and Time Course of SARS-CoV-2 Neutralizing Antibodies. Körper S; Jahrsdörfer B; Corman VM; Pilch J; Wuchter P; Blasczyk R; Müller R; Tonn T; Bakchoul T; Schäfer R; Juhl D; Schwarz T; Gödecke N; Burkhardt T; Schmidt M; Appl T; Eichler H; Klüter H; Drosten C; Seifried E; Schrezenmeier H Transfus Med Hemother; 2021 May; 48(3):137-147. PubMed ID: 34177417 [TBL] [Abstract][Full Text] [Related]
14. Association between COVID-19 convalescent plasma antibody levels and COVID-19 outcomes stratified by clinical status at presentation. Park H; Yu C; Pirofski LA; Yoon H; Wu D; Li Y; Tarpey T; Petkova E; Antman EM; Troxel AB; BMC Infect Dis; 2024 Jun; 24(1):639. PubMed ID: 38926676 [TBL] [Abstract][Full Text] [Related]
15. Multi-center matched cohort study of convalescent plasma for hospitalized patients with COVID-19. Zhou CK; Bennett MM; Villa CH; Hammonds KP; Lu Y; Ettlinger J; Priest EL; Gottlieb RL; Davis S; Mays E; Clarke TC; Shoaibi A; Wong HL; Anderson SA; Kelly RJ PLoS One; 2022; 17(8):e0273223. PubMed ID: 35980913 [TBL] [Abstract][Full Text] [Related]
16. Early but not late convalescent plasma is associated with better survival in moderate-to-severe COVID-19. Briggs N; Gormally MV; Li F; Browning SL; Treggiari MM; Morrison A; Laurent-Rolle M; Deng Y; Hendrickson JE; Tormey CA; Desruisseaux MS PLoS One; 2021; 16(7):e0254453. PubMed ID: 34320004 [TBL] [Abstract][Full Text] [Related]
17. Randomized clinical trial to evaluate safety and efficacy of convalescent plasma use among hospitalized patients with COVID-19 (PERUCONPLASMA): a structured summary of a study protocol for a randomized controlled trial. Soto A; Krapp F; Vargas A; Cabrejos L; Argumanis E; García PL; Altamirano K; Montes M; Chacón-Uscamaita PR; García PJ Trials; 2021 May; 22(1):342. PubMed ID: 34001174 [TBL] [Abstract][Full Text] [Related]
18. Variant of Concern-Matched COVID-19 Convalescent Plasma Usage in Seronegative Hospitalized Patients. Franchini M; Focosi D; Percivalle E; Beccaria M; Garuti M; Arar O; Pecoriello A; Spreafico F; Greco G; Bertacco S; Ghirardini M; Santini T; Schiavulli M; Stefania M; Gagliardo T; Sammartino JC; Ferrari A; Zani M; Ballotari A; Glingani C; Baldanti F Viruses; 2022 Jun; 14(7):. PubMed ID: 35891421 [TBL] [Abstract][Full Text] [Related]
19. Efficacy and Safety of COVID-19 Convalescent Plasma in Hospitalized Patients-An Open-Label Phase II Clinical Trial. Grubovic Rastvorceva RM; Useini S; Stevanovic M; Demiri I; Petkovic E; Franchini M; Focosi D Life (Basel); 2022 Oct; 12(10):. PubMed ID: 36295001 [TBL] [Abstract][Full Text] [Related]
20. Lessons learned from the use of COVID-19 convalescent plasma at Kaiser Permanente. Tse K; Chen Q; Padilla A; Martinez K; Salazar A; Aidikoff J; Soliven S; Sintef A; Palmer-Toy D; Platz B; Shafi H; Zemek A J Allergy Clin Immunol Glob; 2022 Nov; 1(4):309-311. PubMed ID: 36051399 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]